PolyPeptide Group AG (LON:0AAJ)
London
· Delayed Price · Currency is GBP · Price in CHF 20.64
+0.14 (0.69%)
At close: Jun 27, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 614.32 million as of June 27, 2025. Its market cap has decreased by -35.63% in one year.
Market Cap
614.32M
Enterprise Value
645.67M
Revenue
278.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.64
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.04B to 614.32M, a decrease of -69.88%. That is a compound annual growth rate of -25.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 614.32M | -25.57% |
| Dec 30, 2024 | 825.31M | 53.37% |
| Dec 29, 2023 | 538.12M | -28.11% |
| Dec 30, 2022 | 748.55M | -79.59% |
| Dec 30, 2021 | 3.67B | 79.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.54B |
| GSK plc | 58.70B |
| Haleon | 34.55B |
| Smith & Nephew | 9.34B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.47B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.34B |